Literature DB >> 27902514

Prevalence and epidemiology of hepatitis D among patients with chronic hepatitis B virus infection: a report from Northern Spain.

Carlos Ordieres1, Carmen A Navascués, María L González-Diéguez, Mercedes Rodríguez, Valle Cadahía, María Varela, Luis Rodrigo, Manuel Rodríguez.   

Abstract

BACKGROUND: The incidence of hepatitis delta virus (HDV) infection has decreased during the last decades. However, an increasing trend has been reported recently. PATIENTS AND METHODS: We carried out a case-control study to analyze changes in its prevalence in 1215 chronic hepatitis B virus (HBV) patients, diagnosed consecutively in a tertiary center, between 1983 and 2012. According to the year of diagnosis, patients were distributed into two groups: A [1983-1997 (n=786)] and B [1998-2012 (n=429)].
RESULTS: The prevalence of anti-HDV was 8.2% (9.4% in group A and 6.1% in group B) (P=0.04). Multivariate regression revealed that intravenous drug use [odds ratio (OR) 261.0; 95% confidence interval (CI), 28.7-2368.5; P<0.001], blood transfusion (OR 28.0; 95% CI, 2.7-295.9; P=0.03), anti-HIV(+) (OR 4.8; 95% CI, 1.6-14.5; P=0.004), and high alanine aminotransferase (OR 14.4; 95% CI, 3.4-60.6; P<0.001) were associated independently with the presence of anti-HDV in group A, whereas in group B, it was associated with immigration (OR 20.0; 95% CI, 4.7-84.9; P<0.001), intravenous drug use (OR 683.5; 95% CI, 52.7-8855.7; P<0.001), promiscuous sexual activity (OR 22.6; 95% CI, 2.2-228.5; P=0.008), and high alanine aminotransferase (OR 3.4; 95% CI, 1.1-10.0; P=0.02).
CONCLUSION: Although a significant decrease in the prevalence of HDV infection has been observed, it is still above 5%. Immigration and sexual transmission have emerged as new risk factors for HDV infection.

Entities:  

Mesh:

Year:  2017        PMID: 27902514     DOI: 10.1097/MEG.0000000000000795

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  6 in total

1.  Human immunodeficiency virus and liver disease: A comprehensive update.

Authors:  Kenneth E Sherman; Marion G Peters; David Thomas
Journal:  Hepatol Commun       Date:  2017-11-06

Review 2.  Recent advances in managing hepatitis D.

Authors:  Cihan Yurdaydin
Journal:  F1000Res       Date:  2017-08-30

3.  The epidemiological characterization and geographic distribution of hepatitis D virus infection in Libya.

Authors:  Mohamed Ali Daw; Amina Mohamed Daw; Nadia Emhemed Mohamed Sifennasr; Aisha Draha; Ahmed Daw; Ali Daw; Mohamed Ahmed; Ebtisam Mokhtar; Abdallah El-Bouzedi; Ibrahem Daw; Samia Adam; Saed Warrag
Journal:  Pan Afr Med J       Date:  2020-04-14

4.  Implementation of anti-HDV reflex testing among HBsAg-positive individuals increases testing for hepatitis D.

Authors:  Adriana Palom; Ariadna Rando-Segura; Judit Vico; Beatriz Pacín; Elena Vargas; Ana Barreira-Díaz; Francisco Rodríguez-Frías; Mar Riveiro-Barciela; Rafael Esteban; Maria Buti
Journal:  JHEP Rep       Date:  2022-07-21

5.  Hepatitis D virus infection in a large cohort of immigrants in southern Italy: a multicenter, prospective study.

Authors:  Pisaturo Mariantonietta; Alessio Loredana; Di Fraia Alessandra; Macera Margherita; Minichini Carmine; Cordua Emanuele; Onorato Lorenzo; Scotto Gaetano; Di Caprio Giovanni; Calò Federica; Sagnelli Caterina; Coppola Nicola
Journal:  Infection       Date:  2022-10-12       Impact factor: 7.455

6.  Estimating the proportion of people with chronic hepatitis B virus infection eligible for hepatitis B antiviral treatment worldwide: a systematic review and meta-analysis.

Authors:  Mingjuan Tan; Ajeet S Bhadoria; Fuqiang Cui; Alex Tan; Judith Van Holten; Philippa Easterbrook; Nathan Ford; Qin Han; Ying Lu; Marc Bulterys; Yvan Hutin
Journal:  Lancet Gastroenterol Hepatol       Date:  2020-11-14
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.